R & D

Our state-of-the-art API research and development center with a dedicated workforce keenly focusing on innovation and the development of ground-breaking technologies focused on manufacturing Active Pharmaceutical Ingredients, their intermediates and the development of new methods of analysis and testing. With a highly skilled and focused team of scientists, we are bringing forth groundbreaking products to our ever-expanding portfolio.

Focus through this center is to:

  • To develop the process for API’s, API Intermediates, NCE Intermediates for regulated and nonregulated markets
  • To improve the process efficiency of current biological products
  • Cost-effective & Environmentally friendly processes.

Our current projects focus on developing multiple therapeutic segments for the company, these range from:

  • Antipsychotic
  • Cholangitis
  • Anticonvulsant / Antiepileptic
  • Anticoagulant Drugs
  • Antioarkianson
  • Anesthetic Drugs
  • Bile Acid Disorder
  • Antituberculosis

We are currently working on:

  • Daltaparin Sodium
  • Bovine pancreatine
  • Pepsin
  • Cholic acid and its derivatives
  • Trypsin
  • Collagen